ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

Project-002

Active
Institution
Seattle Children's Hospital, WA
Principal investigator
Kenneth D Stuart
Funding
$161K
Duration
2017–2027
Open portfolio

Moonbase score

Still being scored

Abstract

The overall goal of HIPC3 Project 2 is to identify human molecular signatures induced by HIV-1 vaccines and adjuvant formulations that are of potential relevance to protection against HIV-1 infection in diverse populations. Our proposed investigations will focus on three areas where critical insights are needed: 1) comprehensive assessment and comparison of the quality and enhanced potency and durability of immune responses following immunization with a soluble native-like Env trimer formulated with different adjuvants, 2) evaluation of lymph node germinal cell activities and B cell function and phenotype that have the potential to initiate development of HIV-1 broad neutralizing antibodies, and 3) advance high-throughput systems to interrogate the HIV-specific T cell repertoire following vaccination and identify profiles that may associate with immune protection in partially efficacious vaccine trials. Embedded in these studies will be selected analyses of response signatures in unique tissue sources and in diverse populations. These investigations will accelerate progress toward an effective vaccine by probing innate and adaptive immune responses at an unprecedented level in humans.

Research team

  • Margaret Juliana McelrathPI
  • Kenneth D StuartPI
  • Troy R TorgersonPI

LOADING MOONBASE SCORE

NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESU19ZAI1-TC-X(J1)signaturestrimervaccineimmune responsesdiverse populationshiv-project-hiv-specific

Questions for Seattle Children's Hospital

Answered by the team behind this research.

No questions yet. Sign in to ask the first one

Related grants

Same researchers, same institution, same topic, scored first.